Suscripción a Biblioteca: Guest
Portal Digitalde Biblioteca Digital eLibros Revistas Referencias y Libros de Ponencias Colecciones
Critical Reviews™ in Biomedical Engineering
SJR: 0.207 SNIP: 0.376 CiteScore™: 0.79

ISSN Imprimir: 0278-940X
ISSN En Línea: 1943-619X

Volumen 47, 2019 Volumen 46, 2018 Volumen 45, 2017 Volumen 44, 2016 Volumen 43, 2015 Volumen 42, 2014 Volumen 41, 2013 Volumen 40, 2012 Volumen 39, 2011 Volumen 38, 2010 Volumen 37, 2009 Volumen 36, 2008 Volumen 35, 2007 Volumen 34, 2006 Volumen 33, 2005 Volumen 32, 2004 Volumen 31, 2003 Volumen 30, 2002 Volumen 29, 2001 Volumen 28, 2000 Volumen 27, 1999 Volumen 26, 1998 Volumen 25, 1997 Volumen 24, 1996 Volumen 23, 1995

Critical Reviews™ in Biomedical Engineering

DOI: 10.1615/CritRevBiomedEng.2014010999
pages 469-481

Advances in Alginate Gel Microencapsulation of Therapeutic Cells

Barjor Gimi
Biomedical NMR Research Center Department of Radiology and Medicine Geisel School of Medicine at Dartmouth Lebanon, NH, 03756 USA
Krishnamurthy V. Nemani
Department of Radiology, Geisel School of Medicine at Dartmouth, Hanover, NH; Department of Medicine, Geisel School of Medicine at Dartmouth, Hanover, NH, USA


Rapid developments in the therapeutic applications of genetically engineered cells and stem cell research have increased the possibilities of addressing some pathologies by grafting therapeutic cells. Immunoprotective encapsulation of such therapeutic cells is often essential for their survival and function. Hydrogels provide a bioteolerable matrix for cellular encapsulation and support subsequent graft survival and function. The naturally occurring marine polysaccharide, alginate, is the hydrogel of choice for most applications. However, long-term graft survival is affected by the mechanical instability of alginate and adverse immune reaction to its grafting. So, a variety of modifications have been developed to enhance the physicochemical properties and biotolerance of alginate hydrogels. We highlight the developments in alginate hydrogel microencapsulation of therapeutic cells.

Articles with similar content:

Encapsulated Cell Grafts to Treat Cellular Deficiencies and Dysfunction
Critical Reviews™ in Biomedical Engineering, Vol.39, 2011, issue 6
Barjor Gimi, N.V. Krishnamurthy
Role of Solid-Gas Interface of Nanobubbles for Therapeutic Applications
Critical Reviews™ in Therapeutic Drug Carrier Systems, Vol.35, 2018, issue 5
Pravin K. Shende, R. S. Gaud, Drashti Desai
Alternative Scaffolds as Therapeutics in Cancer and Other Diseases
Forum on Immunopathological Diseases and Therapeutics, Vol.5, 2014, issue 1-2
Dragan Grabulovski, Ulrich Wuellner
New Approaches to Antigen Delivery
Critical Reviews™ in Therapeutic Drug Carrier Systems, Vol.17, 2000, issue 3
David FitzGerald, Randall J. Mrsny
Nanoparticulate Carriers Used as Vaccine Adjuvant Delivery Systems
Critical Reviews™ in Therapeutic Drug Carrier Systems, Vol.36, 2019, issue 5
Rui Qian, Ting Liu, Tingni Wu, Ning Wang, Ting Wang